The global pharmacogenomics services market is expected to witness high growth, attributing to the global increase in the prevalence of infectious diseases and various types of cancers, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, rise in the rate of adverse drug reactions, and surge in the usage of pharmacogenomics for drug discovery and...